S&P 500   4,350.40 (-1.18%)
DOW   34,223.13 (-0.63%)
QQQ   359.40 (-1.41%)
AAPL   174.56 (-0.53%)
MSFT   320.71 (-0.02%)
META   297.44 (-0.74%)
GOOGL   131.18 (-1.91%)
AMZN   130.20 (-3.76%)
TSLA   256.81 (-2.20%)
NVDA   413.87 (-2.02%)
NIO   8.48 (-3.85%)
BABA   84.19 (-1.81%)
AMD   96.65 (-3.68%)
T   15.35 (-1.29%)
F   12.19 (-1.38%)
MU   68.31 (-1.97%)
CGC   0.77 (-11.53%)
GE   113.62 (-1.07%)
DIS   82.63 (+0.08%)
AMC   7.75 (-5.02%)
PFE   32.95 (-1.99%)
PYPL   58.80 (-3.38%)
NFLX   384.99 (-0.34%)
S&P 500   4,350.40 (-1.18%)
DOW   34,223.13 (-0.63%)
QQQ   359.40 (-1.41%)
AAPL   174.56 (-0.53%)
MSFT   320.71 (-0.02%)
META   297.44 (-0.74%)
GOOGL   131.18 (-1.91%)
AMZN   130.20 (-3.76%)
TSLA   256.81 (-2.20%)
NVDA   413.87 (-2.02%)
NIO   8.48 (-3.85%)
BABA   84.19 (-1.81%)
AMD   96.65 (-3.68%)
T   15.35 (-1.29%)
F   12.19 (-1.38%)
MU   68.31 (-1.97%)
CGC   0.77 (-11.53%)
GE   113.62 (-1.07%)
DIS   82.63 (+0.08%)
AMC   7.75 (-5.02%)
PFE   32.95 (-1.99%)
PYPL   58.80 (-3.38%)
NFLX   384.99 (-0.34%)
S&P 500   4,350.40 (-1.18%)
DOW   34,223.13 (-0.63%)
QQQ   359.40 (-1.41%)
AAPL   174.56 (-0.53%)
MSFT   320.71 (-0.02%)
META   297.44 (-0.74%)
GOOGL   131.18 (-1.91%)
AMZN   130.20 (-3.76%)
TSLA   256.81 (-2.20%)
NVDA   413.87 (-2.02%)
NIO   8.48 (-3.85%)
BABA   84.19 (-1.81%)
AMD   96.65 (-3.68%)
T   15.35 (-1.29%)
F   12.19 (-1.38%)
MU   68.31 (-1.97%)
CGC   0.77 (-11.53%)
GE   113.62 (-1.07%)
DIS   82.63 (+0.08%)
AMC   7.75 (-5.02%)
PFE   32.95 (-1.99%)
PYPL   58.80 (-3.38%)
NFLX   384.99 (-0.34%)
S&P 500   4,350.40 (-1.18%)
DOW   34,223.13 (-0.63%)
QQQ   359.40 (-1.41%)
AAPL   174.56 (-0.53%)
MSFT   320.71 (-0.02%)
META   297.44 (-0.74%)
GOOGL   131.18 (-1.91%)
AMZN   130.20 (-3.76%)
TSLA   256.81 (-2.20%)
NVDA   413.87 (-2.02%)
NIO   8.48 (-3.85%)
BABA   84.19 (-1.81%)
AMD   96.65 (-3.68%)
T   15.35 (-1.29%)
F   12.19 (-1.38%)
MU   68.31 (-1.97%)
CGC   0.77 (-11.53%)
GE   113.62 (-1.07%)
DIS   82.63 (+0.08%)
AMC   7.75 (-5.02%)
PFE   32.95 (-1.99%)
PYPL   58.80 (-3.38%)
NFLX   384.99 (-0.34%)
NASDAQ:BMRN

BioMarin Pharmaceutical (BMRN) News Today

$86.21
-2.17 (-2.46%)
(As of 02:40 PM ET)
Compare
Today's Range
$86.19
▼
$88.24
50-Day Range
$85.71
▼
$94.48
52-Week Range
$80.53
▼
$117.77
Volume
604,345 shs
Average Volume
1.29 million shs
Market Capitalization
$16.22 billion
P/E Ratio
165.79
Dividend Yield
N/A
Price Target
$115.62
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability
SourceHeadline
marketbeat.com logoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stake Boosted by DNB Asset Management AS
marketbeat.com - September 21 at 4:20 AM
MarketBeat logoBioMarin Pharmaceutical (NASDAQ:BMRN) Receives New Coverage from Analysts at UBS Group
americanbankingnews.com - September 19 at 4:14 AM
finance.yahoo.com logoBioMarin's share prices fluctuate following Phase 3 clinical trial results
finance.yahoo.com - September 18 at 6:46 PM
MarketBeat logoBioMarin Pharmaceutical (NASDAQ:BMRN) Stock Rating Reaffirmed by Truist Financial
americanbankingnews.com - September 17 at 2:50 AM
MarketBeat logoBioMarin Pharmaceutical (NASDAQ:BMRN) Earns Neutral Rating from Wedbush
americanbankingnews.com - September 16 at 4:34 AM
msn.com logoTruist Securities Reiterates Biomarin Pharmaceutical Inc. - Registered Shares (BMRN) Buy Recommendation
msn.com - September 15 at 8:26 PM
marketbeat.com logoTruist Financial Reaffirms Buy Rating for BioMarin Pharmaceutical (NASDAQ:BMRN)
marketbeat.com - September 15 at 12:28 PM
markets.businessinsider.com logoBioMarin Pharma: CHMP Adopts Positive Opinion To Expand Indication For VOXZOGO
markets.businessinsider.com - September 15 at 10:25 AM
finance.yahoo.com logoBioMarin Receives Positive CHMP Opinion in Europe to Expand Use of VOXZOGO® (vosoritide) to Treat Children Aged 4 Months and Older with Achondroplasia
finance.yahoo.com - September 15 at 10:25 AM
MarketBeat logoBioMarin Pharmaceutical (NASDAQ:BMRN) Receives Sector Perform Rating from Royal Bank of Canada
americanbankingnews.com - September 15 at 2:52 AM
MarketBeat logoBioMarin Pharmaceutical's (BMRN) "Buy" Rating Reiterated at Guggenheim
americanbankingnews.com - September 15 at 2:52 AM
MarketBeat logoBioMarin Pharmaceutical's (BMRN) "Overweight" Rating Reaffirmed at Cantor Fitzgerald
americanbankingnews.com - September 15 at 2:52 AM
marketbeat.com logoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Bought by DnB Asset Management AS
marketbeat.com - September 14 at 11:44 AM
markets.businessinsider.com logoWhat 16 Analyst Ratings Have To Say About Biomarin Pharmaceutical
markets.businessinsider.com - September 13 at 5:35 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Altimmune (ALT) and BioMarin Pharmaceutical (BMRN)
markets.businessinsider.com - September 13 at 8:29 AM
markets.businessinsider.com logoBioMarin Pharmaceutical (BMRN) Receives a Rating Update from a Top Analyst
markets.businessinsider.com - September 13 at 8:29 AM
marketbeat.com logoFrontier Capital Management Co. LLC Reduces Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - September 12 at 12:41 PM
finance.yahoo.com logoBioMarin to Present Innovative Pipeline at R&D Day on September 12th in New York
finance.yahoo.com - September 11 at 3:23 PM
marketbeat.com logoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Acquired by Aequim Alternative Investments LP
marketbeat.com - September 8 at 2:34 PM
marketbeat.com logoFmr LLC Has $53.64 Million Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - September 7 at 5:12 AM
finance.yahoo.com logoBioMarin to Present Pipeline at Upcoming R&D Day on Tuesday, September 12th
finance.yahoo.com - September 6 at 9:47 AM
marketbeat.com logoPrudential PLC Has $858,000 Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - September 6 at 7:51 AM
finance.yahoo.com logoBioMarin to Participate in Three Upcoming Investor Conferences
finance.yahoo.com - September 5 at 6:38 PM
stocknews.com logo3 Brilliant Biotech Stocks to Buy for Your Portfolio
stocknews.com - September 1 at 9:10 PM
marketbeat.com logoMartingale Asset Management L P Has $9.32 Million Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - September 1 at 11:22 AM
marketbeat.com logoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Bought by Carmignac Gestion
marketbeat.com - August 31 at 5:48 PM
markets.businessinsider.com logoWedbush Reaffirms Their Hold Rating on BioMarin Pharmaceutical (BMRN)
markets.businessinsider.com - August 31 at 5:08 PM
finance.yahoo.com logoWhy Is Incyte (INCY) Down 0.7% Since Last Earnings Report?
finance.yahoo.com - August 31 at 5:08 PM
finance.yahoo.com logoBioMarin Announces First Person Treated Commercially with ROCTAVIAN® (valoctocogene roxaparvovec-rvox) for Severe Hemophilia A in Europe
finance.yahoo.com - August 30 at 6:31 PM
marketbeat.com logoNomura Asset Management Co. Ltd. Raises Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - August 30 at 9:29 AM
finance.yahoo.com logoBiomarin Pharmaceutical Inc (BM8.BE)
finance.yahoo.com - August 26 at 8:33 AM
marketbeat.com logoIntech Investment Management LLC Acquires 12,413 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - August 25 at 7:21 AM
marketbeat.com logoSkandinaviska Enskilda Banken AB publ Boosts Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - August 22 at 8:26 AM
marketbeat.com logoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Position Trimmed by L & S Advisors Inc
marketbeat.com - August 18 at 9:34 AM
marketbeat.com logoBioMarin Pharmaceutical (NASDAQ:BMRN) Now Covered by StockNews.com
marketbeat.com - August 17 at 4:10 AM
marketbeat.com logoHenry J. Fuchs Sells 12,000 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock
marketbeat.com - August 11 at 4:24 PM
marketbeat.com logoMitsubishi UFJ Kokusai Asset Management Co. Ltd. Has $6.44 Million Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - August 11 at 5:35 AM
marketbeat.com logoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives Consensus Recommendation of "Moderate Buy" from Analysts
marketbeat.com - August 8 at 2:20 AM
marketbeat.com logoBioMarin Pharmaceutical Inc. to Post FY2023 Earnings of $1.19 Per Share, Cantor Fitzgerald Forecasts (NASDAQ:BMRN)
marketbeat.com - August 4 at 10:42 AM
marketbeat.com logoRobeco Institutional Asset Management B.V. Acquires 4,640 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - August 4 at 5:36 AM
markets.businessinsider.com logoRBC Capital Sticks to Its Hold Rating for BioMarin Pharmaceutical (BMRN)
markets.businessinsider.com - August 3 at 11:36 PM
markets.businessinsider.com logoBioMarin Pharmaceutical (BMRN) Receives a Buy from Truist Financial
markets.businessinsider.com - August 3 at 8:34 AM
marketbeat.com logoWestpac Banking Corp Grows Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - August 2 at 7:00 AM
msn.com logoCantor Fitzgerald Reiterates Biomarin Pharmaceutical Inc. - Registered Shares (BMRN) Overweight Recommendation
msn.com - August 2 at 5:12 AM
markets.businessinsider.com logoAnalysts Are Bullish on These Healthcare Stocks: Tenet Healthcare (THC), BioMarin Pharmaceutical (BMRN)
markets.businessinsider.com - August 2 at 5:12 AM
finance.yahoo.com logoQ2 2023 Biomarin Pharmaceutical Inc Earnings Call
finance.yahoo.com - August 1 at 7:11 PM
finance.yahoo.com logoBioMarin (BMRN) Q2 Earnings & Sales Top, Voxzogo Drives Sales
finance.yahoo.com - August 1 at 7:11 PM
finance.yahoo.com logoBioMarin (BMRN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
finance.yahoo.com - July 31 at 11:55 PM
markets.businessinsider.com logoBiomarin Pharmaceutical Inc. Q2 Profit Increases, beats estimates
markets.businessinsider.com - July 31 at 6:54 PM
finance.yahoo.com logoBioMarin Announces Strong Second Quarter 2023 Results and Record Breaking Revenues for the First Half of 2023, Including 13% Year Over Year Growth Year-to-date
finance.yahoo.com - July 31 at 6:54 PM
Get BioMarin Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter.



BMRN Media Mentions By Week

BMRN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BMRN
News Sentiment
▼
0.58

0.46
▲
Average
Medical
News Sentiment

BMRN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BMRN Articles
This Week
▼
15

5
▲
BMRN Articles
Average Week

Get BioMarin Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:BMRN) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -